Literature DB >> 9774464

Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system.

H F Ding1, G McGill, S Rowan, C Schmaltz, A Shimamura, D E Fisher.   

Abstract

The mechanism by which p53 modulates apoptosis in cancer therapy is incompletely understood. Here, cell-free extracts from irradiated tumor cells are described in which endogenous p53 protein is shown to participate in caspase activation. This apoptotic activity is also oncogene-dependent, but independent of transcription in general or the presence of Bax or cytochrome c. A general use for this system is as a cell-free screen for apoptosis modulators. In this way, profound effects of protein kinase A were identified and corroborated in vivo by the protection conferred by cAMP against diverse triggers of p53-dependent apoptosis. This system provides direct biochemical evidence that p53 protein can transduce apoptotic signals through protein-protein interactions and reveals a modulator kinase pathway capable of regulating p53-dependent caspase activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774464     DOI: 10.1074/jbc.273.43.28378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  p53 and cancer therapy: a double-edged sword.

Authors:  G McGill; D E Fisher
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 3.  p53's believe it or not: lessons on transcription-independent death.

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

Review 4.  p53-mediated neuronal cell death in ischemic brain injury.

Authors:  Li-Zhi Hong; Xiao-Yuan Zhao; Hui-Ling Zhang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

5.  Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.

Authors:  Atsuo Yoshino; Yoichi Katayama; Takakazu Yokoyama; Takao Watanabe; Akiyoshi Ogino; Takashi Ota; Chiaki Komine; Takao Fukushima; Kaoru Kusama
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

6.  Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation.

Authors:  M D Johnson; Y Kinoshita; H Xiang; S Ghatan; R S Morrison
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 7.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

Review 8.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

9.  Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain.

Authors:  E Christine Pietsch; Erin Perchiniak; Adrian A Canutescu; Guoli Wang; Roland L Dunbrack; Maureen E Murphy
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

10.  Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.

Authors:  Tohru Yamada; Masatoshi Goto; Vasu Punj; Olga Zaborina; Mei Ling Chen; Kazuhide Kimbara; Dibyen Majumdar; Elizabeth Cunningham; Tapas K Das Gupta; Ananda M Chakrabarty
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.